4.5 Article

Cardiac work is related to creatine kinase energy supply in human heart failure: a cardiovascular magnetic resonance spectroscopy study

期刊

出版社

BMC
DOI: 10.1186/s12968-018-0491-6

关键词

Translational studies; Cardiac metabolism; Cardiac work; Heart failure; Magnetic resonance

资金

  1. AHA [13GRNT17050100]
  2. NIH [R01 HL61912]
  3. NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061912] Funding Source: NIH RePORTER

向作者/读者索取更多资源

BackgroundIt has been hypothesized that the supply of chemical energy may be insufficient to fuel normal mechanical pump function in heart failure (HF). The creatine kinase (CK) reaction serves as the heart's primary energy reserve, and the supply of adenosine triphosphate (ATP flux) it provides is reduced in human HF. However, the relationship between the CK energy supply and the mechanical energy expended has never been quantified in thehuman heart. This study tests whether reduced CK energy supply is associated with reduced mechanical work in HF patients.MethodsCardiac mechanical work and CK flux in W/kg, and mechanical efficiency were measured noninvasively at rest using cardiac pressure-volume loops, magnetic resonance imaging and phosphorus spectroscopy in 14 healthy subjects and 27 patients with mild-to-moderate HF.ResultsIn HF, the resting CK flux (12646 vs. 17950W/kg, p<0.002), the average (6.8 +/- 3.1 vs. 10.1 +/- 1.5W/kg, p<0.001) and the peak (32 +/- 14 vs. 48 +/- 8W/kg, p<0.001) cardiac mechanical work-rates, as well as the cardiac mechanical efficiency (53%+/- 16 vs. 79%+/- 3, p<0.001), were all reduced by a third compared to healthy subjects. In addition, cardiac CK flux correlated with the resting peak and average mechanical power (p<0.01), and with mechanical efficiency (p=0.002).Conclusion p id=Par4 These first noninvasive findings showing that cardiac mechanical work and efficiency in mild-to-moderate human HF decrease proportionately with CK ATP energy supply, are consistent with the energy deprivation hypothesis of HF. CK energy supply exceeds mechanical work at rest but lies within a range that may be limiting with moderate activity, and thus presents a promising target for HF treatment.Trial registrationClinicalTrials.gov Identifier: NCT00181259.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据